Tern Plc (LON:TERN) secures £400,000 through share placement to boost investments in disruptive IoT tech ventures, with a 16.13% share price discount...
Tern Plc (LON:TERN) updates on the deferral of the Tranche Two fundraising for Device Authority, maintaining its 30% stake with a value of US$5.4 million...
Tern PLC (LON:TERN) is a hybrid venture capital firm specialising in disruptive IoT start-ups. Its portfolio shows strong growth potential. Insights on its financial health, operational highlights, and expert analysis by Progressive Equity Research...
Join Tern Plc for an online presentation and Q&A session on 26 March 2024 at 5.30 p.m. GMT. Register now to hear from management and portfolio companies...
Tern Plc (AIM:TERN) announces that Device Authority Limited has completed an additional fundraising round, securing $2.0 million in new equity investment...
Tern Plc has announced that Talking Medicines has raised £440,000 in new investment through a fundraising round, with Tern contributing £100,000. This funding will support Talking Medicines' growth, particularly in expanding its US activities...
Tern Plc (LON:TERN) secures £400,000 through share placement to boost investments in disruptive IoT tech ventures, with a 16.13% share price discount...
Tern Plc (LON:TERN) updates on the deferral of the Tranche Two fundraising for Device Authority, maintaining its 30% stake with a value of US$5.4 million...
Tern PLC (LON:TERN) is a hybrid venture capital firm specialising in disruptive IoT start-ups. Its portfolio shows strong growth potential. Insights on its financial health, operational highlights, and expert analysis by Progressive Equity Research...
Join Tern Plc for an online presentation and Q&A session on 26 March 2024 at 5.30 p.m. GMT. Register now to hear from management and portfolio companies...
Tern Plc (AIM:TERN) announces that Device Authority Limited has completed an additional fundraising round, securing $2.0 million in new equity investment...
Tern Plc has announced that Talking Medicines has raised £440,000 in new investment through a fundraising round, with Tern contributing £100,000. This funding will support Talking Medicines' growth, particularly in expanding its US activities...
